| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Codexis, Inc. (CDXS) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CDXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 727.1K | $1.72M | - | |
| CEO | 254.3K | $602.8K | - | |
| 10% | 180.0K | $426.6K | - | |
| ? | 139.0K | $329.3K | - | |
| Other | 138.8K | $328.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2018 | Lalonde James | SVP, R&D | Sell | 30,296 | $17.24 | $522,196.68 | -8.1% | |
| Aug 30, 2018 | Kelley Bernard J | Director | Sale+OE | 16,666 | $17.15 | $285,780.24 | -6.9% | |
| Aug 21, 2018 | Sangster Gordon | SVP &Chief Financial Officer | Sell | 18,736 | $15.31 | $286,906.24 | -12.2% | |
| Aug 20, 2018 | Wolf Dennis P77 | Director | Sale+OE | 36,666 | $14.97 | $549,016.52 | -15.0% | |
| Aug 16, 2018 | Yang Patrick Y72 | Director | Sell | 150,340 | $14.45 | $2,172,413.00 | -100% | |
| Aug 15, 2018 | Nicols John J86 | President And CEO | Sale+OE | 14,259 | $15.14 | $215,940.20 | -0.7% | |
| Jul 19, 2018 | Yang Patrick Y72 | Director | Sell | 50,000 | $15.46 | $772,902.50 | -7.3% | |
| Jul 18, 2018 | Glaub Kathleen Sereda | Director | Sell | 10,000 | $15.34 | $153,400.00 | -9.2% | |
| Jul 17, 2018 | Lalonde James | SVP, R&D | Sell | 15,000 | $15.40 | $231,009.75 | -3.6% | |
| Jul 16, 2018 | Dorgan Byron L | Director | Sell | 10,000 | $15.49 | $154,880.00 | -5.0% |